spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Lundbeck 

 HSMN NewsFeed - 5 Jan 2023
ZyVersa Therapeutics Appoints Three New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Nov 2022
Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure(R) Predict Prognostic Test for Alzheimer's Disease
Diagnostics Neurology Personnel
 HSMN NewsFeed - 15 Mar 2022
Neuraxpharm appoints Tom Coogan as new Country Manager for Ireland
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2020
AllianceRx Walgreens Prime One of Only Two Specialty Pharmacies to Distribute Vyepti(TM), the First and Only Intravenous Preventive Treatment for Migraine
Biopharmaceuticals Distribution
 HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 May 2019
Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Nov 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 4 Jan 2018
Acacia Pharma Announces FDA Acceptance of NDA Filing For BAREMSIS(R) for the Management of Post-operative Nausea & Vomiting
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jan 2018
Enterome Raises €32 Million ($38.5 Million) in a Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Aug 2017
Amplyx Pharmaceuticals Raises $67 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jul 2017
Enterome and Nestlé Health Science Launch New Diagnostics Company
Diagnostics
 HSMN NewsFeed - 23 Jun 2017
Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix(R) (vortioxetine) sNDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jun 2017
Axovant Strengthens Executive Team with Key Management Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Mar 2017
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 23 Jan 2017
Neuropore Therapies Announces Appointment of Dr. Errol De Souza as President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Jan 2017
Vtesse Announces Appointment of Jason Meyenburg as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2016
Bristol-Myers Squibb and Enterome SA Announce Immuno-Oncology Collaboration Focused on Microbiome-derived Biomarkers, Drug Targets and Bioactive Molecules
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 3 Nov 2016
Enterome Appoints Christophe Bonny as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2016
BONESUPPORT(TM) Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value From CERAMENT(TM) Injectable Drug Eluting Bioceramic Platform
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 20 Apr 2016
Enterome Raises EUR14.5 Million in Series C Financing Round
Biopharmaceuticals Gastroenterology Venture Capital
 HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 Feb 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jan 2016
Acorda to Acquire Biotie Therapies
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 11 Jan 2016
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
Biopharmaceuticals Oncology Ophthalmology Venture Capital
 HSMN NewsFeed - 6 Jan 2016
Vernalis Announces Corvus Pharmaceuticals, Inc. as Its Worldwide Licensee for Their Adenosine Antagonist Program
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Nov 2015
Insys Therapeutics Announces Senior Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2015
Galleon Pharmaceuticals Names Joseph Oliveto as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2015
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2015
Spero Completes $30 Million Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 6 May 2015
Gilead Sciences Acquires EpiTherapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2014
Naurex Raises $80 Million in Series C Financing to Advance Novel NMDA Receptor Modulators in Depression and Other CNS Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Dec 2014
Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Aug 2014
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2014
Enterome Raises €10 million in Series B Fund Raising
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Nov 2013
Otsuka and Lundbeck's Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Apr 2013
Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 5 Sep 2012
Civitas Therapeutics Appoints Bryan E. Stuart Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Jul 2012
PsiOxus Therapeutics Secures £22 Million ($34 Million) in Series B Financing to Drive Clinical Development for Oncolytic Vaccine
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Apr 2012
AlloCure Raises $25 Million Series B Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Nov 2011
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2011
FDA Approves ONFI(TM) (clobazam) for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Patients Two Years and Older
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2011
Noven Appoints Lance D. Williams as Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2010
GTC Biotherapeutics Regains US Rights to ATryn(R) ; the First Recombinant Antithrombin Product Approved in the World
Biopharmaceuticals
 HSMN NewsFeed - 26 Apr 2010
Mylan Begins Marketing First Generic Version of Desoxyn(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 Mar 2010
APP Pharmaceuticals Receives Approval for Indomethacin for Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Dec 2009
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2009
Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 10 Jul 2009
Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Biopharmaceuticals Litigation Generics
 HSMN NewsFeed - 10 Jul 2009
Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation
Biopharmaceuticals Litigation Generics
 HSMN NewsFeed - 11 Jun 2009
Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2008
Myriad Genetics Selects Lundbeck as European Partner for Flurizan
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 May 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
Biopharmaceuticals
 HSMN NewsFeed - 29 Feb 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2007
New Data Reinforces the Superiority of Escitalopram Over Duloxetine for Acute Treatment of Depression
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2007
Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
Biopharmaceuticals
 HSMN NewsFeed - 30 Oct 2007
Gene Logic Selects New Company Name: Ore Pharmaceuticals Inc.
Biopharmaceuticals
 HSMN NewsFeed - 5 Sep 2007
Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Jul 2007
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2007
Biotechnology Start-up Nuon Therapeutics Inc. Completes $5 Million Series A Financing and Names Management Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 20 Jun 2007
Novagali Pharma Strengthens its Executive Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2007
Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2) Do Not Demonstrate Difference Between Desmoteplase and Placebo
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Apr 2007
Osprey Pharmaceuticals Limited Appoints Jack M. Anthony to the Newly Created Position of Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2007
Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
Biopharmaceuticals
 HSMN NewsFeed - 28 Mar 2007
Merck & Co., Inc. and Lundbeck Discontinue Joint Development Program for Gaboxadol, an Investigational Compound for Insomnia
Biopharmaceuticals
 HSMN NewsFeed - 8 Mar 2007
Astion Pharma Prepares Management Structure for Bringing Pharmaceuticals to Market
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2007
Lundbeck USA Signs Lease Agreement to Establish U.S. Headquarters in King of Prussia, Pennsylvania
Biopharmaceuticals
 HSMN NewsFeed - 18 Jan 2007
Cipralex Approved in Europe for the Treatment of Obsessive Compulsive Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2006
Bifeprunox Showed Improvement of Symptoms and Maintenance of Stability with Fewer Metabolic Side Effects vs. Placebo in Patients with Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2006
Phase 2 and 3 Clinical Data for Bifeprunox in Patients With Schizophrenia Showed Improvement of Symptoms and Maintenance of Stability With Fewer Metabolic Side Effects Versus Placebo
Biopharmaceuticals
 HSMN NewsFeed - 13 Oct 2006
Merck & Co., Inc. and Lundbeck Announce Update in Submission Plans for U.S. Approval of Gaboxadol
Biopharmaceuticals
 HSMN NewsFeed - 14 Jul 2006
Forest Announces Federal Court Upholds Lexapro(R) Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Jul 2006
Medicure Appoints Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2006
Forest Laboratories, Inc. and H. Lundbeck A/S File Lawsuit Against Caraco Pharmaceutical Laboratories, Ltd. for Patent Infringement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 May 2006
Second Investigational Study of SEROQUEL(R) in the Treatment of Depressive Episodes Associated with Bipolar Disorder Confirms Previous Findings
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
Biopharmaceuticals
 HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA
Return to NewsFeed  

 Additional items found! 52

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 52 additional stories matching:
Lundbeck
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.